VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Biology of Waldenström macroglobulinemia

Véronique Leblond, MD, Hematology at Pitié Salpêtrière Hospital, Paris, France, discusses common genetic variations seen in patients with Waldenström macroglobulinemia and touches on how a greater understanding of the disease, can support treatment strategies, including treatment with ibrutinib, a tyrosine kinase inhibitor. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter